New artery treatment may cut repeat brain bleed risk
NCT ID NCT04750200
First seen Jan 08, 2026 · Last updated May 25, 2026 · Updated 21 times
Summary
This study looks at whether adding a procedure called middle meningeal artery embolization (EMMA) to standard surgery can lower the chance of a chronic subdural hematoma (a type of brain bleed) coming back. About 192 adults in Canada with a symptomatic brain bleed will be randomly assigned to get surgery alone or surgery plus EMMA. The main goal is to see if the bleed returns within 90 days.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC SUBDURAL HEMATOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Manitoba
Winnipeg, Manitoba, R3E 3P5, Canada
Conditions
Explore the condition pages connected to this study.